{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:41:50Z","timestamp":1787611310688,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.arbres.2019.08.019","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T18:34:06Z","timestamp":1574793246000},"page":"163-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["An Open-label Study With Pirfenidone on Chronic Hypersensitivity Pneumonitis"],"prefix":"10.1016","volume":"56","author":[{"given":"Heidegger","family":"Mateos-Toledo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayra","family":"Mej\u00eda-\u00c1vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d3scar","family":"Rodr\u00edguez-Barreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Guillermo","family":"Mej\u00eda-Hurtado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Rojas-Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Castillo-Pedroza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Castillo-Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Gaxiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivette","family":"Buend\u00eda-Roldan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moises","family":"Selman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbres.2019.08.019_bib0005","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1164\/rccm.201203-0513CI","article-title":"Hypersensitivity pneumonitis: insights in diagnosis and pathobiology","volume":"186","author":"Selman","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2019.08.019_bib0010","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1164\/rccm.201611-2201PP","article-title":"Hypersensitivity pneumonitis: perspectives in diagnosis and management","volume":"196","author":"Vasakova","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2019.08.019_bib0015","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1513\/AnnalsATS.201807-443OC","article-title":"CT Honeycombing identifies a progressive fibrotic phenotype with increased mortality across diverse interstitial lung diseases","volume":"16","author":"Adegunsoye","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.arbres.2019.08.019_bib0020","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.rmed.2010.11.026","article-title":"Morphologic diversity of chronic pigeon breeder's disease: clinical features and survival","volume":"105","author":"Gaxiola","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2019.08.019_bib0025","doi-asserted-by":"crossref","first-page":"109","DOI":"10.5858\/arpa.2017-0173-RA","article-title":"Pathology of chronic hypersensitivity pneumonitis what is it? What are the diagnostic criteria? Why do we care?","volume":"142","author":"Churg","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.arbres.2019.08.019_bib0030","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/all.13692","article-title":"Long-term outcomes in chronic hypersensitivity pneumonitis","volume":"74","author":"Ojanguren","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.arbres.2019.08.019_bib0035","doi-asserted-by":"crossref","DOI":"10.3390\/jcm6060062","article-title":"Fibrotic hypersensitivity pneumonitis: key issues in diagnosis and management","volume":"6","author":"Kouranos","year":"2017","journal-title":"J Clin Med"},{"key":"10.1016\/j.arbres.2019.08.019_bib0040","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.chest.2016.10.029","article-title":"Use of mycophenolate mofetil or azathioprine for the management of chronic hypersensitivity pneumonitis","volume":"151","author":"Morisset","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2019.08.019_bib0045","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2019.08.019_bib0050","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2019.08.019_bib0055","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.molimm.2018.05.003","article-title":"Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation","volume":"99","author":"Li","year":"2018","journal-title":"Mol Immunol"},{"key":"10.1016\/j.arbres.2019.08.019_bib0060","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0014-2999(02)01758-2","article-title":"A novel anti-fibrotic agent pirfenidone suppresses tumor necrosis factor-alpha at the translational level","volume":"446","author":"Nakazato","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.arbres.2019.08.019_bib0065","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/resp.12323","article-title":"Bronchial inflammation in hypersensitivity pneumonitis after antigen-specific inhalation challenge","volume":"19","author":"Villar","year":"2014","journal-title":"Respirology"},{"key":"10.1016\/j.arbres.2019.08.019_bib0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40248-019-0175-6","article-title":"Bronchoalveolar lavage cell profiles and proteins concentrations can be used to phenotype extrinsic allergic alveolitis patients","volume":"14","author":"Sterclova","year":"2019","journal-title":"Multidiscip Respir Med"},{"key":"10.1016\/j.arbres.2019.08.019_bib0075","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1164\/rccm.200701-093OC","article-title":"Functional diversity of T-cell subpopulations in subacute and chronic hypersensitivity pneumonitis","volume":"177","author":"Barrera","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2019.08.019_bib0080","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.arbres.2017.09.004","article-title":"Translation to Spanish and validation of the specific Saint George's Questionnaire for idiopatic pulmonary fibrosis","volume":"54","author":"Capparelli","year":"2018","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2019.08.019_bib0085","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1477-7525-8-77","article-title":"Development of the ATAQ-IPF: a tool to assess quality of life in IPF","volume":"8","author":"Swigris","year":"2010","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.arbres.2019.08.019_bib0090","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s11136-012-0322-4","article-title":"Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study","volume":"22","author":"Janssen","year":"2013","journal-title":"Qual Life Res"},{"key":"10.1016\/j.arbres.2019.08.019_bib0095","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2019.08.019_bib0100","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00016-2017","article-title":"Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis","volume":"3","author":"Adegunsoye","year":"2017","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.arbres.2019.08.019_bib0105","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/thoraxjnl-2013-203265","article-title":"Novel use of rituximab in hypersensitivity pneumonitis refractory to conventional treatment","volume":"68","author":"Lota","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2019.08.019_bib0110","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/resp.12214","article-title":"Rituximab in severe, treatment-refractory interstitial lung disease","volume":"19","author":"Keir","year":"2014","journal-title":"Respirology"},{"key":"10.1016\/j.arbres.2019.08.019_bib0115","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for systemic sclerosis-associated interstitial lung disease","volume":"380","author":"Distler","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2019.08.019_bib0120","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12890-017-0462-y","article-title":"Exploring efficacy and safety of oral pirfenidone for progressive, non-IPF lung fibrosis (RELIEF) \u2013 a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial","volume":"17","author":"Behr","year":"2017","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.arbres.2019.08.019_bib0125","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S2213-2600(13)70191-7","article-title":"Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis: a prospective case-cohort study","volume":"1","author":"Morell","year":"2013","journal-title":"Lancet Respir Med"}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289619303813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289619303813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:37:54Z","timestamp":1759531074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289619303813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0300289619303813"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2019.08.019","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Open-label Study With Pirfenidone on Chronic Hypersensitivity Pneumonitis","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2019.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 SEPAR. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}